State-of-the-art technologies enable a comprehensive digital transformation process in support of international growth for the Padua-based Group, now also involved in the production of glass primary packaging for drugs and the various potential vaccines to fight COVID-19, vaccine inspection equipment and plastic components for diagnostic testing.
